Back
Share
Visit journal website ↗ Compare

Endocrine, Metabolic and Immune Disorders - Drug Targets

ISSN 1871-5303 · 2212-3873

Publisher: Bentham Science Publishers

Scopus · Q3WoS · SCIE

Is Endocrine, Metabolic and Immune Disorders - Drug Targets indexed in Scopus? Yes — actively indexed in Scopus, coverage 2006–2026, best quartile Q3, CiteScore 4.1.

Is Endocrine, Metabolic and Immune Disorders - Drug Targets in Web of Science? Yes — indexed in the Science Citation Index Expanded.

Is Endocrine, Metabolic and Immune Disorders - Drug Targets open access? No — it is not registered as an open-access journal in DOAJ or Scopus.

4.1
CiteScore 2025
Scopus
Q3
Best quartile
48th percentile
2
Indexed in
major indexes
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.

Official sources & links

Journal website ↗ Scopus source ↗ Web of Science ↗

Related journals

Explore this journal in the interactive dashboard →

Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.